Evaluation of Intestinal Patency with the Patency Capsule: The Twenty-Four Hour Assessment Method.


Journal

Digestion
ISSN: 1421-9867
Titre abrégé: Digestion
Pays: Switzerland
ID NLM: 0150472

Informations de publication

Date de publication:
2019
Historique:
received: 06 07 2018
accepted: 15 10 2018
pubmed: 22 11 2018
medline: 27 2 2020
entrez: 22 11 2018
Statut: ppublish

Résumé

Confirmation of intestinal patency using the patency capsule (PC) in 30-33 h may result in a complex testing schedule. The aim of this study was to perform and evaluate a 24-h PC procedure for potential use as a simple and easy-to-apply intestinal patency assessment method. The study included 342 patients who were assessed 24 h after ingesting a PC for assessment of intestinal patency. The PC elimination rate and the distribution of elimination time were evaluated. Assessment of intestinal patency was conducted in 308 (90%) patients. Self-confirmed PC elimination within 24 h was possible in 104 (30.4%) patients. The PC was considered to have been already eliminated in 38 (11.1%) patients. Thus, the extracorporeal elimination rate was 41.5%. Among 200 patients with non-extracorporeal elimination, the PC reached the large intestine in 166 patients (48.5% of the total patients). Small-bowel capsule endoscopy (CE) was performed in all 308 patients, and the entire small bowel could be observed in 98.4%. Capsule retention was not observed in any of the patients. The 24-h assessment method, in which the PC can be ingested using the same procedure as that for CE capsule, can be handled more easily and is more useful clinically.

Identifiants

pubmed: 30463059
pii: 000494717
doi: 10.1159/000494717
doi:

Substances chimiques

Capsules 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

176-185

Informations de copyright

© 2018 S. Karger AG, Basel.

Auteurs

Teppei Omori (T)

Institute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan, tohmori@ige.twmu.ac.jp.

Harutaka Kambayashi (H)

Institute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan.

Shun Murasugi (S)

Institute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan.

Ayumi Ito (A)

Institute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan.

Maria Yonezawa (M)

Institute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan.

Shinichi Nakamura (S)

Institute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan.

Katsutoshi Tokushige (K)

Institute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH